The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Acromegaly and Gigantism Drugs Market Research Report 2025
Synopsis
Gigantism refers to abnormally high linear growth due to excessive action of insulinlike growth factor I (IGF-I) while the epiphyseal growth plates are open during childhood. Acromegaly is the same disorder of IGF-I excess but occurs after the growth plate cartilage fuses in adulthood.
The global Acromegaly and Gigantism Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global acromegaly and gigantism treatment market can be segmented into treatment, end users, and geographical expansion. On the basis of treatment, the market is divided into surgery, radiation therapy, and medication. The medication segment can be further divided into different drug types such as somatostatin analogs, GH receptor antagonists, dopamine agonists and others. The medication segment is expected to hold a significant market share during the forecast period due to factors such as effectiveness of drugs, noninvasive and lesser side effects than radiation therapies, and strong pipeline portfolio.
This report aims to provide a comprehensive presentation of the global market for Acromegaly and Gigantism Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acromegaly and Gigantism Drugs.
Report Scope
The Acromegaly and Gigantism Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acromegaly and Gigantism Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acromegaly and Gigantism Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ipsen
Novartis
Pfizer
Segment by Type
Somatostatin Analogs
GH Receptor Antagonists
Dopamine Agonists
Recombinant Human IGF-1
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Acromegaly and Gigantism Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Acromegaly and Gigantism Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Gigantism refers to abnormally high linear growth due to excessive action of insulinlike growth factor I (IGF-I) while the epiphyseal growth plates are open during childhood. Acromegaly is the same disorder of IGF-I excess but occurs after the growth plate cartilage fuses in adulthood.
The global Acromegaly and Gigantism Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global acromegaly and gigantism treatment market can be segmented into treatment, end users, and geographical expansion. On the basis of treatment, the market is divided into surgery, radiation therapy, and medication. The medication segment can be further divided into different drug types such as somatostatin analogs, GH receptor antagonists, dopamine agonists and others. The medication segment is expected to hold a significant market share during the forecast period due to factors such as effectiveness of drugs, noninvasive and lesser side effects than radiation therapies, and strong pipeline portfolio.
This report aims to provide a comprehensive presentation of the global market for Acromegaly and Gigantism Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acromegaly and Gigantism Drugs.
Report Scope
The Acromegaly and Gigantism Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acromegaly and Gigantism Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acromegaly and Gigantism Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ipsen
Novartis
Pfizer
Segment by Type
Somatostatin Analogs
GH Receptor Antagonists
Dopamine Agonists
Recombinant Human IGF-1
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Acromegaly and Gigantism Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Acromegaly and Gigantism Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Acromegaly and Gigantism Drugs Market Overview
1.1 Product Overview and Scope of Acromegaly and Gigantism Drugs
1.2 Acromegaly and Gigantism Drugs Segment by Type
1.2.1 Global Acromegaly and Gigantism Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Somatostatin Analogs
1.2.3 GH Receptor Antagonists
1.2.4 Dopamine Agonists
1.2.5 Recombinant Human IGF-1
1.3 Acromegaly and Gigantism Drugs Segment by Application
1.3.1 Global Acromegaly and Gigantism Drugs Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Acromegaly and Gigantism Drugs Market Size Estimates and Forecasts
1.4.1 Global Acromegaly and Gigantism Drugs Revenue 2019-2030
1.4.2 Global Acromegaly and Gigantism Drugs Sales 2019-2030
1.4.3 Global Acromegaly and Gigantism Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Acromegaly and Gigantism Drugs Market Competition by Manufacturers
2.1 Global Acromegaly and Gigantism Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Acromegaly and Gigantism Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Acromegaly and Gigantism Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Acromegaly and Gigantism Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Acromegaly and Gigantism Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Acromegaly and Gigantism Drugs, Product Type & Application
2.7 Acromegaly and Gigantism Drugs Market Competitive Situation and Trends
2.7.1 Acromegaly and Gigantism Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Acromegaly and Gigantism Drugs Players Market Share by Revenue
2.7.3 Global Acromegaly and Gigantism Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Acromegaly and Gigantism Drugs Retrospective Market Scenario by Region
3.1 Global Acromegaly and Gigantism Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Acromegaly and Gigantism Drugs Global Acromegaly and Gigantism Drugs Sales by Region: 2019-2030
3.2.1 Global Acromegaly and Gigantism Drugs Sales by Region: 2019-2024
3.2.2 Global Acromegaly and Gigantism Drugs Sales by Region: 2025-2030
3.3 Global Acromegaly and Gigantism Drugs Global Acromegaly and Gigantism Drugs Revenue by Region: 2019-2030
3.3.1 Global Acromegaly and Gigantism Drugs Revenue by Region: 2019-2024
3.3.2 Global Acromegaly and Gigantism Drugs Revenue by Region: 2025-2030
3.4 North America Acromegaly and Gigantism Drugs Market Facts & Figures by Country
3.4.1 North America Acromegaly and Gigantism Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Acromegaly and Gigantism Drugs Sales by Country (2019-2030)
3.4.3 North America Acromegaly and Gigantism Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Acromegaly and Gigantism Drugs Market Facts & Figures by Country
3.5.1 Europe Acromegaly and Gigantism Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Acromegaly and Gigantism Drugs Sales by Country (2019-2030)
3.5.3 Europe Acromegaly and Gigantism Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Acromegaly and Gigantism Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Acromegaly and Gigantism Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Acromegaly and Gigantism Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Acromegaly and Gigantism Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Acromegaly and Gigantism Drugs Market Facts & Figures by Country
3.7.1 Latin America Acromegaly and Gigantism Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Acromegaly and Gigantism Drugs Sales by Country (2019-2030)
3.7.3 Latin America Acromegaly and Gigantism Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Acromegaly and Gigantism Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Acromegaly and Gigantism Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Acromegaly and Gigantism Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Acromegaly and Gigantism Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Acromegaly and Gigantism Drugs Sales by Type (2019-2030)
4.1.1 Global Acromegaly and Gigantism Drugs Sales by Type (2019-2024)
4.1.2 Global Acromegaly and Gigantism Drugs Sales by Type (2025-2030)
4.1.3 Global Acromegaly and Gigantism Drugs Sales Market Share by Type (2019-2030)
4.2 Global Acromegaly and Gigantism Drugs Revenue by Type (2019-2030)
4.2.1 Global Acromegaly and Gigantism Drugs Revenue by Type (2019-2024)
4.2.2 Global Acromegaly and Gigantism Drugs Revenue by Type (2025-2030)
4.2.3 Global Acromegaly and Gigantism Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Acromegaly and Gigantism Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Acromegaly and Gigantism Drugs Sales by Application (2019-2030)
5.1.1 Global Acromegaly and Gigantism Drugs Sales by Application (2019-2024)
5.1.2 Global Acromegaly and Gigantism Drugs Sales by Application (2025-2030)
5.1.3 Global Acromegaly and Gigantism Drugs Sales Market Share by Application (2019-2030)
5.2 Global Acromegaly and Gigantism Drugs Revenue by Application (2019-2030)
5.2.1 Global Acromegaly and Gigantism Drugs Revenue by Application (2019-2024)
5.2.2 Global Acromegaly and Gigantism Drugs Revenue by Application (2025-2030)
5.2.3 Global Acromegaly and Gigantism Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Acromegaly and Gigantism Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Ipsen
6.1.1 Ipsen Corporation Information
6.1.2 Ipsen Description and Business Overview
6.1.3 Ipsen Acromegaly and Gigantism Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Ipsen Acromegaly and Gigantism Drugs Product Portfolio
6.1.5 Ipsen Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Acromegaly and Gigantism Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Acromegaly and Gigantism Drugs Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Acromegaly and Gigantism Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Acromegaly and Gigantism Drugs Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Acromegaly and Gigantism Drugs Industry Chain Analysis
7.2 Acromegaly and Gigantism Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Acromegaly and Gigantism Drugs Production Mode & Process
7.4 Acromegaly and Gigantism Drugs Sales and Marketing
7.4.1 Acromegaly and Gigantism Drugs Sales Channels
7.4.2 Acromegaly and Gigantism Drugs Distributors
7.5 Acromegaly and Gigantism Drugs Customers
8 Acromegaly and Gigantism Drugs Market Dynamics
8.1 Acromegaly and Gigantism Drugs Industry Trends
8.2 Acromegaly and Gigantism Drugs Market Drivers
8.3 Acromegaly and Gigantism Drugs Market Challenges
8.4 Acromegaly and Gigantism Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
